Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cellectar Biosciences, Inc. | Chief Commercial Officer | Stock option (right to buy) | 260K | Jun 14, 2024 | Direct | ||
Cellectar Biosciences, Inc. | Chief Commercial Officer | Common Stock | 39.6K | Dec 8, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CLRB | Cellectar Biosciences, Inc. | Jun 14, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Chief Commercial Officer |
CLRB | Cellectar Biosciences, Inc. | Jun 23, 2023 | 2 | $0 | 4 | Dec 12, 2023 | Chief Commercial Officer |
CLRB | Cellectar Biosciences, Inc. | Nov 21, 2022 | 1 | $0 | 4 | Dec 15, 2022 | Chief Commercial Officer |
CLRB | Cellectar Biosciences, Inc. | Nov 21, 2022 | 0 | $0 | 3 | Dec 15, 2022 | Chief Commercial Officer |